| # | Drug | Count |
|---|---|---|
| 0 | COPPER | 354 |
| 1 | ADALIMUMAB | 312 |
| 2 | LEVONORGESTREL | 150 |
| 3 | FLUOXETINE HYDROCHLORIDE | 144 |
| 4 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 125 |
| 5 | NEVIRAPINE | 125 |
| 6 | NICOTINE | 118 |
| 7 | NICOTINE POLACRILEX | 115 |
| 8 | LAMOTRIGINE | 114 |
| 9 | NICOTINE POLACRILEX MINI | 114 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIMOZIDE | 11 | 0.0228 |
| 1 | NEVIRAPINE | 125 | 0.0139 |
| 2 | ZIDOVUDINE | 97 | 0.0094 |
| 3 | COPPER | 354 | 0.0082 |
| 4 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 2 | 0.0063 |
| 5 | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | 3 | 0.0057 |
| 6 | OXYTOCIN | 16 | 0.0053 |
| 7 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 125 | 0.0051 |
| 8 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 2 | 0.0046 |
| 9 | LAMIVUDINE | 105 | 0.0042 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 356 | 0.0072 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 133 | 0.0055 |
| 2 | Oxytocic [EPC] | 16 | 0.0053 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 106 | 0.0022 |
| 4 | Prostacycline [EPC] | 2 | 0.0021 |
| 5 | Cholinergic Nicotinic Agonist [EPC] | 120 | 0.0020 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 12 | 0.0016 |
| 7 | Insulin [EPC] | 63 | 0.0014 |
| 8 | Provitamin D2 Compound [EPC] | 35 | 0.0012 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 116 | 0.0011 |